Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called ex... ( -- Disaster recovery-ready for multi...)

Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)

Date:9/10/2007

-- Disaster recovery-ready for multi-site active or hot-standby

deployment,

-- Centralized single sign-on audit log with built-in reporting,

-- And an array of fixed-fee services and support options to meet the

specific needs of each organization.

For almost a decade, Sentillion has been at the forefront of innovation when it comes to delivering solutions that help healthcare organizations overcome the challenges associated with identity and access management. The first company to bring an SSO solution on a network appliance to market, Sentillion's IAM solutions are the most widely deployed in healthcare and used daily by more than 275,000 caregivers.

"With our unwavering commitment to bringing our customers live, Sentillion has clearly established itself as the lowest risk, highest value option among all identity and access management offerings," said Robert Seliger, Sentillion's CEO. "Now, with expreSSO we are delighted to make the core benefits of our technology even more appealing by offering healthcare organizations a new option: an affordable SSO solution that quickly and easily improves caregiver satisfaction and provides an immediate return on investment."

Pricing & Availability

For pricing details, please contact Sentillion directly. The product will be generally available in Q4 2007.

For More Information

To learn more about expreSSO, please visit http://www.sentillion.com/expresso.

About Sentillion

Since 1998, Sentillion has been revolutionizing healthcare IT with award winning, industry recognized identity and access management technology. Sentillion has successfully combined patented technology with a deep understanding of the healthcare industry to deliver the most comprehensive set of solutions for single sign-on, user provisioning, clinical workstations and virtualized remote access. Sentillion is the onl
'/>"/>

SOURCE Sentillion, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. E Merck introduces Livogen Z with zinc sulphate
2. TI Cycles Introduces Foldman
3. Canada Introduces Mandatory Nutrition Labeling
4. Amgen introduces Autoinjector For Treating Anemia
5. Cuba Introduces New Device for Detecting Vascular Diseases
6. China Introduces Solar-powered Baths
7. Allergan Introduces ‘Dermal Filler’ for Smile Lins
8. UAE Introduces Cervical Cancer Vaccine
9. Cynosure Introduces Higher Power Smartlipo(TM) LaserBodySculpting Workstation
10. Iceland Introduces Smoking Ban in Bars and Restaurants
11. Indian Introduces Paan-flavoured Condoms

Post Your Comments:

(Date:5/21/2013)... May 22, 2013 Feed additives have ... production industry value chain. Most of the feed additives ... injectable, pellets, liquids, and powders. There are variety of ... and concentrations depending upon the type of animal and ... vitamins that provide essential nutrition to the animal in ...

(Date:5/21/2013)... (PRWEB) May 21, 2013 Medical Ministry ... the prestigious 2013 Top-Rated Award by GreatNonprofits , the ... are excited to be named a Top-Rated 2013 Nonprofit,” says ... the dedication of our over 3000 Volunteers and Staff serving ... significant as it came from those that have seen our ...

(Date:5/21/2013)... on a large scale is the cornerstone of ... better outcomes, better value and better experience of ... patient-centered medical home model offers a viable solution ... of Health and Human Services, Agency for Healthcare ... more about the processes and determinants of successful ...

(Date:5/21/2013)... 21, 2013 Mecklenburg EMS Agency (Medic) ... hold a free Community Wellness Fair to educate the public ... will be held on Wednesday, May 22, 2013 from 4:00 ... (8100 Old Mallard Creek Road, Charlotte, NC 29262). ... and the Mecklenburg County Department of Social Services ...

(Date:5/21/2013)... May 2013, Paris, France: The Orsiro stent, which ... a biodegradable polymer, demonstrated non-inferiority to the Xience ... of in-stent late lumen loss at nine months ... at EuroPCR 2013 today. , The BIOFLOW-II substudy ... (OCT) to quantitatively assess neointimal hyperplasia and stent ...

Breaking Medicine News(10 mins):Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 2 Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 3 Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 4 Health News:Medical Ministry International Recognized as a 2013 Top-rated Nonprofit By GreatNonprofits.org 2 Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 2 Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 3 Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 4 Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 5 Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 6 Health News:Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives 2 Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2

[0] Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com [0] Medical Ministry International Recognized as a 2013 Top-rated Nonprofit By GreatNonprofits.org [0] AHRQ-funded journal supplement offers lessons on primary care practice transformation [0] Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives [0] Biodegradable stent proves non-inferior to drug-eluting stent

... 12 The Female Health Company (NYSE Alternext: ... (FDA) Obstetrics and Gynecology Devices Advisory Committee has unanimously voted ... is approvable with a single condition. , ... the product is approvable with the condition that the FC2 ...

... HOUSTON, Dec. 12 Access MediQuip, LLC, ... medical implantable device management,solutions to the healthcare ... industry,s first national contract for device benefit ... with WellPoint, Inc. to deliver,implantable device management ...

... and only approved peginterferon in combination with ribavirin for ... medical need , , ... SGP ) today announced that the U.S. Food ... PEGINTRON(TM) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, USP) combination therapy ...

... director for the Pew Campaign on Human Health and ... U.S. Food and Drug Administration,s decision to reverse its ... animal agriculture: , , ... the increase in antibiotic-resistant infections - a fact long ...

... Hospitals Case Medical Center in conjunction with Sodexo Health Care ... Nosh 24/6 unit, the original certified kosher hot food vending ... machine in the state of Ohio, offering patients and their ... , , University Hospitals prides ...

... Life Insurance,Company (John Hancock) is reinforcing its commitment ... training requirements through an,affiliation with the ClearCert Clearinghouse. ... in the year and effective January 1, 2009,will ... , Since ...

Cached Medicine News:Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 2 Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 3 Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 4 Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 5 Health News:Access MediQuip and WellPoint Finalize First National Contract for Implantable Medical Devices 2 Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 2 Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 3 Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 4 Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 5 Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 6 Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 7 Health News:Statement From The Pew Charitable Trusts on the U.S. Food and Drug Administration's Reversal on Antibiotics Safeguards in Animal Farming 2 Health News:University Hospitals Case Medical Center Installs First Hot Kosher Vending Machine 2 Health News:University Hospitals Case Medical Center Installs First Hot Kosher Vending Machine 3 Health News:John Hancock Expands LTC Training Effort with ClearCert High Usage By Producers and Streamlines Process for Insurers 2 Health News:John Hancock Expands LTC Training Effort with ClearCert High Usage By Producers and Streamlines Process for Insurers 3

FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable Access MediQuip and WellPoint Finalize First National Contract for Implantable Medical Devices Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C Statement From The Pew Charitable Trusts on the U.S. Food and Drug Administration's Reversal on Antibiotics Safeguards in Animal Farming University Hospitals Case Medical Center Installs First Hot Kosher Vending Machine John Hancock Expands LTC Training Effort with ClearCert High Usage By Producers and Streamlines Process for Insurers

(Date:5/21/2013)... 21, 2013 Lakeland Industries, Inc. (NASDAQ: ... industrial protective clothing for industry, municipalities, healthcare and ... levels, today announced that the Company accepted a ... Credit Facility subject to certain terms and conditions ... However, no assurances can be given that this ...

(Date:5/21/2013)... May 21, 2013 Regulus Therapeutics Inc . ... discovery and development of innovative medicines targeting microRNAs, today ... Ph.D., Chief Operating Officer and Executive Vice President, Finance, ... 38th Annual Healthcare Conference on Wednesday, May 29, 2013 ... at the Westin Boston Waterfront Hotel. The ...

(Date:5/21/2013)... , May 21, 2013 Tom Daulton, CEO of Mammotome, ... of the Year by the Cincinnati ... was nominated by another local top executive who is also ... brand from Ethicon Endo-Surgery in March of 2010. Daulton will ... Awards program, presented by Huntington Bank, on May 22. ...

[0] Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results [0] Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference [0] Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year

... - VASTox plc (AIM: VOX), a leading,UK biotechnology ... of £400,000 by the Welsh Development Agency,(”WDA”) under ... 12 months, will support the research and development,work ... the unique skills and expertise of its scientists,based ...

... 2007 /PRNewswire-USNewswire/ -- The,following statement may be attributed ... Medical Research (CAMR): , "In the face of ... the stroke of his veto pen deliberately to ... well as endanger,the future health and well being ...

Cached Medicine Technology:Vastox Awarded £400,000 Grant to Support R&D at,Carbohydrate Chemistry Facility 2 Vastox Awarded £400,000 Grant to Support R&D at,Carbohydrate Chemistry Facility 3 President Bush Ignores America's Plea for Support of Stem Cell,Research 2

Vastox Awarded £400,000 Grant to Support R&D at,Carbohydrate Chemistry Facility President Bush Ignores America's Plea for Support of Stem Cell,Research

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

Medicine Products:

Dapsone, Serum or Plasma Dalmane D-lysergic Acid Diethylamide, Urine D, 1-25 Dihydroxy, Vitamin